Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
fkansteiner
Tue, 03/02/2021 – 09:32